Trials / Completed
CompletedNCT06083116
Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide
Evaluation of Drug-drug Interaction Between Henagliflozin Proline and Hydrochlorothiazide in Healthy Chinese Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A single-center, single-arm, open-label, multi-dose, three-period study was conducted in healthy Chinese volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydrochlorothiazide、Henagliflozin Proline | Hydrochlorothiazide and Henagliflozin Proline |
Timeline
- Start date
- 2019-08-28
- Primary completion
- 2019-10-10
- Completion
- 2019-10-10
- First posted
- 2023-10-13
- Last updated
- 2023-10-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06083116. Inclusion in this directory is not an endorsement.